Liftstream is an executive search recruitment company in the life sciences sector
GenSight investment profits from gene therapy buzz
Authored by James Sheppard
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases
Tagged Abingworth LLP, Bernard Gilly, Bluebird bio, Boehringer Ingelheim, celgene, Gene therapy, GenSight Biologics, Glybera, Index Ventures, Jen Bennet, Leber’s Hereditary Optic Neuropathy, Novartis Venture Funds, Paris, Professor Jose-Alain Sahel, Transgene, uniQure, University of Pennsylvania, Vision Institute
Leave a comment